Last updated: July 11, 2023
Sponsor: Medstar Health Research Institute
Overall Status: Active - Recruiting
Phase
1
Condition
N/ATreatment
Ketorolac
Oxycodone
Clinical Study ID
NCT05054868
STUDY00001123
Ages 18-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 - 75 years.
- Women of childbearing potential must have a negative serum or urine pregnancy testresults within 24 hours before the first dose of ketorolac.
- Primary elective great toe MTP arthrodesis (CPT 28750). Other forefoot proceduresoften performed in conjunction with toe fusion will be included (CPT codes 28308, 28285, 28270).
Exclusion
Exclusion Criteria:
- Chronic pain syndrome, CRPS or fibromyalgia
- Revision procedures
- Use of allograft bone at the fusion site
- Tobacco use
- Diabetes
- Narcotic abuse or IV drug abuse
- Any CPT codes involving the midfoot, hindfoot, and/or ankle
- Unable to take NSAIDs secondary to medical comorbidities such as kidney disease (impaired renal function with CrCl ≤ 50 ml/min) or gastric ulcers
- Weight < 50 kg
- Does not speak or read English
- If pregnant or planning to become pregnant or breastfeeding
- Non-independent dweller (prisoner)
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Ketorolac
Phase: 1
Study Start date:
April 14, 2020
Estimated Completion Date:
July 31, 2024
Study Description
Connect with a study center
Amy Loveland
Baltimore, Maryland 21218
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.